First AI Pathology Program Approved: Helps Detect Prostate Cancer

The US Food and Drug Administration (FDA) has authorized marketing of artificial intelligence (AI) software to help pathologists detect prostate cancer. The program, called Paige Prostate, is the first approved AI system in pathology. "We really believe this product can make a huge difference," Paige CEO Leo Grady, PhD, told Medscape Medical News. The program was approved as an adjunct to pathologist review, not a replacement. Grady explained that "for a second opinion today, you ship a glass slide to somebody else or you do another stain that's really expensive or you do another molecular test."